Near fatal anaphylaxis from orally administered gelatin capsule

J Allergy Clin Immunol Pract. 2013 Jan;1(1):99-100. doi: 10.1016/j.jaip.2012.09.004. Epub 2012 Nov 27.

Authors

Michael H Land¹, Mark D Piehl, A Wesley Burks

Affiliation

¹ Duke University School of Medicine, Durham, NC. Electronic address: michael.h.land@kp.org.

PMID: 24229830
DOI: 10.1016/j.jaip.2012.09.004

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Administration, Oral
Adrenergic alpha-Agonists / therapeutic use
Anaphylaxis / chemically induced*
Anaphylaxis / drug therapy
Anti-Allergic Agents / therapeutic use
Anti-Inflammatory Agents / therapeutic use
Anti-Inflammatory Agents, Non-Steroidal / administration & dosage
Capsules
Child
Diphenhydramine / therapeutic use
Epinephrine / therapeutic use
Famotidine / therapeutic use
Female
Follow-Up Studies
Gelatin / administration & dosage
Gelatin / adverse effects*
Histamine H2 Antagonists / therapeutic use
Humans
Ibuprofen / administration & dosage
Prednisone / therapeutic use
Treatment Outcome

Substances

Adrenergic alpha-Agonists
Anti-Allergic Agents
Anti-Inflammatory Agents
Anti-Inflammatory Agents, Non-Steroidal
Capsules
Histamine H2 Antagonists
Famotidine
Diphenhydramine
Gelatin
Prednisone
Ibuprofen
Epinephrine